Cannara Locks Multi-Year Supply Deal with Curaleaf International
Canadian cultivator secures long-term export agreement as international cannabis trade accelerates amid global market expansion.
Cannara Biotech has secured a multi-year cannabis supply agreement with Curaleaf International Limited, marking another step in the growing cross-border cannabis trade between established North American operators. The deal positions Cannara as a key supplier to Curaleaf's international operations, which span multiple European markets where medical cannabis demand continues expanding.
The agreement comes as Canadian licensed producers increasingly pivot toward international markets to offset domestic headwinds. Canada's recreational market has faced pricing pressures and oversupply issues, pushing cultivators to seek higher-margin export opportunities. Curaleaf's international division operates in Germany, the UK, and other European jurisdictions where medical cannabis programs are maturing rapidly.
For Curaleaf, the supply partnership strengthens its international inventory pipeline as European markets scale up. The company has been building its European footprint through acquisitions and partnerships, competing against other multi-state operators like Green Thumb Industries and Cresco Labs for international expansion opportunities. Access to reliable, large-scale Canadian cultivation helps support this geographic diversification strategy.
The deal structure reflects broader industry consolidation trends, where larger operators secure supply chains through long-term partnerships rather than costly facility buildouts in new markets. This approach allows companies like Curaleaf to maintain inventory flexibility while Canadian producers gain revenue visibility in higher-value international channels.
Canadian cannabis exports reached CAD $216 million in 2023, with medical products driving most international sales. Multi-year supply agreements like this one provide revenue stability for Canadian cultivators while supporting the infrastructure needed for North American operators to compete globally against European cannabis companies expanding their own production capabilities.